Study | 84.4% of Cancer Patients Taking Ivermectin + Mebendazole Reported No Evidence of Disease, Tumor Regression, or Cancer Stabilization After 6 Months
PaulCraigRoberts.org
Epidemiologist Nicolas Hulscher breaks down the findings:
Nicolas Hulscher | GlobalResearch.ca
84.4% of the cancer patients taking ivermectin + mebendazole reported no evidence of disease, tumor regression, or cancer stabilization after 6 months.
Real-World Clinical Outcomes of Ivermectin and Mebendazole in Cancer PatientsReal-World Clinical Outcomes of
